Related Articles
Higher efficacy and complete response with administration of eribulin for recurrent squamous cell breast carcinoma: A case report
Evaluation of a trastuzumab-containing treatment regimen for patients with unresectable advanced or recurrent gastric cancer
Neoadjuvant pertuzumab in non‑metastatic HER2‑positive breast tumors: Multicentric study in Peru (NeoHer)
Pathological complete response rate in hormone receptor-negative breast cancer treated with neoadjuvant FEC, followed by weekly paclitaxel administration: A retrospective study and review of the literature
Examination of the clinical usefulness of TS-1 in locally recurrent breast cancer